By Tony Fong

Thermo Fisher Scientific has entered into a collaboration with the UK's Institute of Cancer Research as part of a new integrative network biology initiative underway at the institute that is using proteomics and other –omics methods to decipher how cancer cell networks interact with each other in order to metastasize.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.